Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever
Clinical trial NCT01224639 · COMPLETED
Trial details
- NCT number
- NCT01224639
- Sponsor
- Inviragen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-11
- Primary completion
- 2011-06-09
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.